Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
26 /100
MEDIUM RISK
Score updated Oct 13, 2026

PBYI — Puma Biotechnology, Inc. Dilution Risk Tracker

Track PBYI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PBYI — Get alerts when the score changes →

As of October 13, 2026, Puma Biotechnology, Inc. (PBYI) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Puma Biotechnology, Inc. has a market capitalization of $531.17M, 51.62M shares outstanding, 158 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰Cash Runway—
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for PBYI.
🔔 Track PBYI — Get forecast alerts →

Market Data

Market Cap$531.17M
Shares Outstanding51.62M
Float39.09M
Cash$93.90M
Debt$11.28M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore26/100DilutionWatch score record
Shares Outstanding51.62MVerified float table or market cache
Public Float39.09MVerified float table or market cache
Market Cap$531.17MMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 16.6% shares (2026Q1 vs prior)
158 institutional holders · 41.95M shares
#1 ACORN CAPITAL ADVISORS, LLC 4.13M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 3.64M shares
#3 BlackRock, Inc. 3.60M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.26M
Days to Cover14.0
% of Float10.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2014-03-03
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PBYI Dilution Snapshot

Puma Biotechnology, Inc. (PBYI) has a DilutionScore of 26/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PBYI's DilutionScore is currently 26/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 22/100 (Low risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202626/100MEDIUM60 days
Jul 16 – Aug 13, 202622/100LOW29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PBYI shares outstanding have increased 0.0% from 50.89M (May 2026) to 50.90M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 11, 202650.90M39.09M▲ 0.05%
May 01, 202650.89M39.07M▲ 0.16%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PBYI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PBYI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PBYI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PBYI
PBYI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.